ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2019

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.

David M Faleck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.